Tumor mutational burden assessed by a targeted NGS assay predicts clinical benefit from immune checkpoint inhibitors in non-small cell lung cancer

被引：0
|
作者：
Jermann, P. [1 ]
Alborelli, I. [1 ]
Leonards, K. [1 ]
Rothschild, S. I. [2 ]
Leuenberger, L. [1 ]
Prince, S. Savic [1 ]
Mertz, K. [3 ]
Poechtrager, S. [3 ]
Zippelius, A. [2 ]
Quagliata, L. [4 ]
Bubendorf, L. [1 ]
机构：
[1] Univ Hosp Basel, Inst Pathol, Basel, Switzerland
[2] Univ Spital Basel, Basel, Switzerland
[3] Kantonsspital Liestal, Med Univ Klin, Liestal, Switzerland
[4] Univ Spital Basel, Pathol, Basel, Switzerland
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
161P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Tumor Mutational Burden Assessed by a Targeted NGS Assay Predicts Benefit from Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Rothschild, S.
    Jermann, P.
    Savic, S.
    Mertz, K.
    Zippelius, A.
    Quagliata, L.
    Bubendorf, L.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S735 - S736
  • [2] Tumor mutational burden assessed by a targeted NGS assay predicts benefit from immune checkpoint inhibitors in non-small cell lung cancer
    Rothschild, S. I.
    Jermann, P.
    Savic, S.
    Mertz, K. D.
    Poechtrager, S.
    Zippelius, A.
    Quagliata, L.
    Bubendorf, L.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 234 - 234
  • [3] Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non-small cell lung cancer
    Alborelli, Ilaria
    Leonards, Katharina
    Rothschild, Sacha, I
    Leuenberger, Laura P.
    Prince, Spasenija Savic
    Mertz, Kirsten D.
    Poechtrager, Severin
    Buess, Martin
    Zippelius, Alfred
    Laubli, Heinz
    Haegele, Jasmin
    Tolnay, Markus
    Bubendorf, Lukas
    Quagliata, Luca
    Jermann, Philip
    JOURNAL OF PATHOLOGY, 2020, 250 (01): : 19 - 29
  • [4] Tumor mutational burden assessed by a targeted NGS assay to predict benefit from immune checkpoint inhibitors in non-small cell lung cancer
    Rothschild, Sacha
    Jermann, Philip
    Savic, Spasenija
    Mertz, Kirsten
    Zippelius, Alfred
    Quagliata, Luca
    Bubendorf, Lukas
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Tumor mutational burden assessed by a targeted NGS assay to predict clinical benefit from immune checkpoint inhibitors in non-small cell lung cancer.
    Rothschild, Sacha
    Alborelli, Ilaria
    Leonards, Katharina
    Leuenberger, Laura P.
    Prince, Spasenija Savic
    Mertz, Kirsten D.
    Poechtrager, Severin
    Zippelius, Alfred
    Laubli, Heinz Philipp
    Haegele, Jasmin
    Tolnay, Markus
    Bubendorf, Lukas
    Quagliata, Luca
    Jermann, Philip
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] Current views on tumor mutational burden in patients with non-small cell lung cancer treated by immune checkpoint inhibitors
    Berland, Lea
    Heeke, Simon
    Humbert, Olivier
    Macocco, Adam
    Long-Mira, Elodie
    Lassalle, Sandra
    Lespinet-Fabre, Virginie
    Lalvee, Salome
    Bordone, Olivier
    Cohen, Charlotte
    Leroy, Sylvie
    Hofman, Veronique
    Hofman, Paul
    Ilie, Marius
    JOURNAL OF THORACIC DISEASE, 2019, 11 : S71 - S80
  • [7] Decrease of benefit from immune checkpoint inhibitors in women with non-small cell lung cancer
    Pinto, Joseph A.
    Mas, Luis A.
    Vallejos, Carlos S.
    Araujo, Jhajaira
    Bravo, Leny
    Aguilar, Alfredo
    Morante, Zaida
    Bretel, Denisse
    Gomez, Henry L.
    Rolfo, Christian
    CANCER RESEARCH, 2017, 77
  • [8] THE SUM OF TUMOR SIZE PREDICTS THE EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN NON-SMALL CELL LUNG CANCER
    Shiraishi, Yusuke
    Marumo, Satoshi
    Amimoto, Hisanori
    Yamaki, Haruka
    Shirata, Masahiro
    Imoto, Takamitsu
    Kitajima, Takamasa
    Inoue, Daiki
    Katayama, Yuko
    Fukui, Motonari
    RESPIROLOGY, 2018, 23 : 289 - 289
  • [9] The effect of tumor mutation burden on immune checkpoint inhibitors in non-small cell lung cancer.
    Zhao, Jie
    Dong, Yiting
    Bai, Hua
    Duan, Jianchun
    Wang, Guoqiang
    Xu, Jiachen
    Wang, Zhijie
    Wang, Jie
    CANCER RESEARCH, 2021, 81 (13)
  • [10] The clinical utility of tumor mutational burden in non-small cell lung cancer
    Greillier, Laurent
    Tomasini, Pascale
    Barlesi, Fabrice
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (06) : 639 - 646
12345